BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Best of BioWorld: Q1
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Watson Pharma launches ella emergency contraceptive in U.S.
Dec. 2, 2010
PhaseBio begins phase I/IIa study of Glymera in type 2 diabetes
Dec. 2, 2010
Savient Pharma's Krystexxa is available by prescription in U.S.
Dec. 1, 2010
Worldwide rights to pegsiticase acquired by 3SBio from EnzymeRx
Nov. 30, 2010
Banyu Pharma presents new antagonists of peptide P518 receptor
Nov. 30, 2010
Amarin's pivotal phase III MARINE trial of AMR-101 meets primary endpoints
Nov. 29, 2010
Takeda applies to change Leuplin dosage and administration for CPP in Japan
Nov. 29, 2010
MAA submitted to EMA for taliglucerase alfa in Gaucher's disease
Nov. 29, 2010
Banyu Pharma patents new antagonists of peptide P518 receptor
Nov. 26, 2010
FDA approves testosterone replacement therapy Axiron
Nov. 24, 2010
Previous
1
2
…
650
651
652
653
654
655
656
657
658
…
1792
1793
Next
RSS